Cargando…

Natural history and prognostic factors for localised small bowel adenocarcinoma

OBJECTIVE: Small bowel adenocarcinoma (SBA) is a rare malignancy with limited evidence regarding outcomes after curative resection of localised disease. We aimed to evaluate presentation and prognostic factors affecting overall survival (OS), relapse-free survival (RFS) and recurrence of SBA. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colina, Andreina, Hwang, Hyunsoo, Wang, Huamin, Katz, Matthew H G, Sun, Ryan, Lee, Jeffrey E, Thomas, Jane, Tzeng, Ching-Wei, Wolff, Robert A, Raghav, Kanwal, Overman, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668374/ https://www.ncbi.nlm.nih.gov/pubmed/33188051 http://dx.doi.org/10.1136/esmoopen-2020-000960

Ejemplares similares

Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy
por: Bhamidipati, D., et al.
Publicado: (2021)

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater
por: Gulhati, Pat, et al.
Publicado: (2017)

Reply: Cetuximab in small bowel adenocarcinoma: a new friend?
por: Overman, M J, et al.
Publicado: (2010)

Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction
por: Chouhan, Jay, et al.
Publicado: (2015)

Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes
por: Raghav, Kanwal, et al.
Publicado: (2016)

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma
por: Overman, Michael J., et al.
Publicado: (2016)

Molecular Landscape of Small Bowel Adenocarcinoma
por: Pandya, Karan, et al.
Publicado: (2022)

FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
por: Korphaisarn, Krittiya, et al.
Publicado: (2017)

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery
por: Uemura, Marc, et al.
Publicado: (2017)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
por: Rogers, Jane E., et al.
Publicado: (2020)

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
por: Tong, Yi Tat, et al.
Publicado: (2023)

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience
por: Serpas Higbie, Victoria, et al.
Publicado: (2022)

Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and Perspectives
por: Moati, Emilie, et al.
Publicado: (2022)

Small bowel adenocarcinoma: natural history of recurrence after surgical resection
por: Farina, Massimo, et al.
Publicado: (2022)

Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma
por: Korphaisarn, Krittiya, et al.
Publicado: (2019)

Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
por: Mohindroo, Chirayu, et al.
Publicado: (2021)

Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma
por: Liu, Qingqing, et al.
Publicado: (2017)

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy
por: Liang, Tom Z., et al.
Publicado: (2023)

Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
por: Serpas, Victoria J., et al.
Publicado: (2018)

Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
por: Raghav, Kanwal, et al.
Publicado: (2021)

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine
por: Overman, M J, et al.
Publicado: (2010)

Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait
por: Huey, Ryan W., et al.
Publicado: (2019)

Cancer of Unknown Primary Presenting as Bone‐Predominant or Lymph Node‐Only Disease: A Clinicopathologic Portrait
por: Huey, Ryan W., et al.
Publicado: (2021)

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
por: Aparicio, T, et al.
Publicado: (2013)

Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay
por: Raghav, Kanwal, et al.
Publicado: (2020)

Underreporting of race/ethnicity in COVID-19 research
por: Raghav, Kanwal, et al.
Publicado: (2021)

Prognostic Value of CD1B in Localised Prostate Cancer
por: Lee, Cheng-Hsueh, et al.
Publicado: (2019)

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma
por: Wang, Shan, et al.
Publicado: (2022)

Tibial Plasmablastic Lymphoma in a HIV-Negative Child: A Novel Extraoral Localisation
por: Mala, Ali, et al.
Publicado: (2022)

Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer
por: Raghav, Kanwal, et al.
Publicado: (2020)

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
por: Amer, Ahmed M., et al.
Publicado: (2018)

Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Age as an independent prognostic factor for survival of localised synovial sarcoma patients
por: Vlenterie, Myrella, et al.
Publicado: (2015)

Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma
por: Pan, Hongming, et al.
Publicado: (2021)

Localising photons
por: Omnès, Roland
Publicado: (1994)

Localised Œdema
por: Parker, G.
Publicado: (1895)

The Localisation of Hæmoptysis
Publicado: (1921)

The Localisation of Missiles
Publicado: (1919)

Localised Osteosclerosis
Publicado: (1931)

Localised Peritonitis
por: Baker, C. O.
Publicado: (1896)

Cannot write session to /tmp/vufind_sessions/sess_8413djtkujj62p8jh105lfvqcj